Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ampio Pharmaceuticals Inc (AMPE)  
$0.14 0.01 (9.23%) as of 4:30 Fri 6/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 15,090,000
Market Cap: 2.14(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.13 - $5.76
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ampio Pharmaceuticals is a biopharmaceutical company focused on the research, development and improvement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Ampion, Co.'s primary product candidate is a biologic drug, which contains ingredients that target several pathways in the innate immune response characteristic of inflammatory disease. Ampion is in development as an intra-articular injection treatment for severe Osteoarthritis of the Knee; an intravenous and inhaled treatment for COVID-19 patients; and an at-home inhalation treatment for patients with prolonged respiratory symptoms due to COVID-19.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 318,748
Total Buy Value $0 $0 $0 $81,874
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 8
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 93
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Coelho Philip H Director   –       •      –    2017-09-27 4 B $0.63 $6,270 D/D 10,000 104,727 2.39     -
   Coelho Philip H Director   –       •      –    2017-09-22 4 B $0.60 $1,800 D/D 3,000 94,727 2.31     -
   Coelho Philip H Director   –       •      –    2017-09-20 4 B $0.59 $592 D/D 1,000 91,727 2.31     -
   Coelho Philip H Director   –       •      –    2017-09-19 4 B $0.57 $8,519 D/D 15,000 90,727 2.39     -
   Coelho Philip H Director   –       •      –    2017-09-05 4/A B $0.56 $16,776 D/D 30,000 75,727 2.39     -
   Coelho Philip H Director   –       •      –    2017-09-05 4 S $0.56 $16,776 D/D (30,000) 75,727     -
   Coelho Philip H Director   –       •      –    2017-01-03 4 A $0.96 $19,999 D/D 20,826 45,727     -
   Stevens David R Director   –       •      –    2017-01-03 4 A $0.96 $19,999 D/D 20,826 35,789     -
   Giles Richard B Director   –       •      –    2017-01-03 4 A $0.96 $19,999 D/D 20,826 216,093     -
   Stevens David R Director   –       •      –    2016-01-04 4 A $3.31 $19,999 D/D 6,042 14,963     -
   Coelho Philip H Director   –       •      –    2016-01-04 4 A $3.31 $19,999 D/D 6,042 24,901     -
   Stevens David R Director   –       •      –    2015-01-02 4 A $3.75 $9,998 D/D 2,666 8,921     -
   Giles Richard B Director   –       •      –    2015-01-02 4 A $3.75 $9,998 D/D 2,666 189,225     -
   Coelho Philip H Director   –       •      –    2015-01-02 4 A $3.75 $9,998 D/D 2,666 18,859     -
   Clift Vaughan Lennox Chief Regulatory Affairs   •       –      –    2014-02-25 5 D $8.02 $4,188,044 D/D (522,200) 0     -
   Giles Richard B Director   –       •      –    2014-01-02 4 A $7.13 $10,003 D/D 1,403 186,559     -
   Coelho Philip H Director   –       •      –    2014-01-02 4 A $7.13 $10,003 D/D 1,403 16,193     -
   Stevens David R Director   –       •      –    2014-01-02 4 A $7.13 $10,003 D/D 1,403 6,255     -
   Giles Richard B Director   –       •      –    2013-12-03 4 OE $1.75 $20,857 D/D 11,918 185,156     -
   Macaluso Michael Chief Executive Officer   •       •      –    2013-11-27 4 OE $1.75 $47,913 D/D 27,379 1,786,752     -
   Coelho Philip H Director   –       •      –    2013-11-18 4 S $8.25 $109,666 D/D (13,287) 14,790     -
   Coelho Philip H Director   –       •      –    2013-11-15 4 S $8.22 $93,070 D/D (11,320) 28,077     -
   Bar-Or David Chief Scientific Officer   •       •      –    2013-11-11 4 GD $0.00 $0 D/D 2,700,000 0     -
   Macaluso Michael Chief Executive Officer   •       •      –    2013-10-01 4 GD $0.00 $0 D/D 284,000 1,759,373     -
   Giles Richard B Director   –       •      –    2013-01-18 4 OE $2.20 $116,751 I/I 50,417 50,417     -
  93 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us